Boston Scientific Secures $135.7M Contract for Cardiovascular Products
Boston Scientific (BSX) has been awarded a maximum $135.7 million Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract by the U.S. Department of Defense to supply cardiovascular procedural packages and related items. The five-year agreement, which does not include option periods, will provide medical supplies for use across the Army, Navy, and Air Force through September 29, 2031. The deal is expected to support military healthcare operations with Boston Scientific’s products used in various cardiovascular procedures. This contract win reflects continued demand for Boston Scientific's offerings within government procurement channels and may contribute positively to its revenue outlook.
Tickers: $BSX
Topics: defense_contracts medical_devices